Avance Biosciences is a leading CRO/CTL providing GLP & GMP-compliant assay development, assay validation, and sample testing services to support biological drug development and manufacturing activities world-wide.
Our customized cell and gene therapy assay solutions include: mRNA ID testing, mRNA ratio testing for multi-valent drug product, on/off target analysis of CRISPR edited genes by NGS assays, single cell % transduction assays, vector integration site analysis by NGS, preclinical PK & toxicity biodistribution studies, inserted vector and gene copy number analysis, replication competent lentivirus (RCL) assays, and testing of DNA or mRNA in clinical trial human samples.
Eclipsebio is a private biotechnology company headquartered in San Diego, developing first-in-class technologies to accelerate the development of tomorrow’s key RNA genomics discoveries and medicines. The company offers its end-to-end RNA genomics products as full service solutions and also provides custom RNA genomics services for select partners.
Learn more by visiting us at www.eclipsebio.com.
Elegen brings unique insights and technical innovation to create high-quality synthetic DNA faster, catalyzing the next revolution in the life sciences. The company is led by seasoned leaders with decades of experience in developing novel and scalable approaches in molecular biology, chemistry, and microfluidics. Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries. Founded in 2017, Elegen is privately held and based in the San Francisco Bay Area.
Boston Analytical (BA) is a cGMP, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory. BA has rolled out a comprehensive analytical solution that provides regulatory-tested methodologies for every aspect of characterizing the purity, potency, and identity of mRNA products. BA strives to provide characterization services that are tailored to your mRNA manufacturing platform. Phase-appropriate qualification strategies are employed and non-cGMP in-process/scale-up optimization services offerings are available.
LineaRx, an Applied DNA Sciences, Inc. company, delivers enzymatically-produced LinearDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies. Manufactured by a proprietary, large-scale polymerase chain reaction (“PCR”) based manufacturing platform, LinearDNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences.
If you offer relevant services and would like to align your company within the RNA space, contact us to discuss a bespoke commercial package to promote your brand at one of our Summits in the World RNA Series.
Email firstname.lastname@example.org to request more information.